| |
Preexisting Drug-Resistance Mutations in Treatment-Naive Patients Do Not Affect Response to Tenofovir Disoproxil Fumarate- or Tenofovir Alafenamide-Containing Regimens
|
| |
| |
Reported by Jules Levin
XXV International HIV Drug Resistance Workshop, February 20–21, 2016, Boston, MA
Nicolas A. Margot, Rima Kulkarni, Kirsten White, Danielle Porter, Michael E. Abram, Christian Callebaut, Michael D. Miller
Gilead Sciences, Inc., Foster City, CA
|
|
| |
| |
|
|
|
